Table 4.
Prevalence and expected heterozygosity of the pfnhe-1 ms4760 groups according to the geographical location of the isolates (continent & country)
| ms4760 profiles (%) | Prevalence by Continent/Country | Total | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Africa | Asia | ||||||||
| Congo | Uganda | Kenya | Madagascar | ComorosIslands | India | China/Myanmar | Vietnam | ||
| n = 74 | n = 172 | n = 29 | n = 386 | n = 251 | n = 244 | n = 60 | n = 79 | ||
| ms4760-A | 1.3 | 0.0 | 0.0 | 2.0 | 1.5 | 0.0 | 0.0 | 1.3 | 1.1 |
| ms4760-B | 4.1 | 1.7 | 7.1 | 4.4 | 1.1 | 0.0 | 1.6 | 0.0 | 2.2 |
| ms4760-C | 38.3 | 22.6 | 14.2 | 24.1 | 11.9 | 19.2 | 4.9 | 6.3 | 19.2 |
| ms4760-D | 5.4 | 1.1 | 0.0 | 2.3 | 3.5 | 2.8 | 0.0 | 0.0 | 2.3 |
| ms4760-E | 9.5 | 6.3 | 3.5 | 9.8 | 6.3 | 36.0 | 19.7 | 10.1 | 13.9 |
| ms4760-F | 26.0 | 33.7 | 53.5 | 31.1 | 34.2 | 10.2 | 14.7 | 10.1 | 26.3 |
| ms4760-G | 0.0 | 1.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| ms4760-H | 0.0 | 0.0 | 0.0 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| ms4760-I | 6.8 | 13.9 | 14.2 | 14.0 | 21.5 | 23.2 | 50.8 | 69.6 | 21.9 |
| ms4760-J | 8.2 | 11.0 | 7.1 | 8.5 | 5.1 | 6.5 | 3.3 | 0.0 | 7.0 |
| ms4760-K | 0.0 | 5.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 |
| ms4760-L | 0.0 | 2.3 | 0.0 | 2.3 | 14.3 | 1.6 | 4.9 | 2.6 | 4.5 |
| ms4760-M | 0.0 | 0.0 | 0.0 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| ms4760-N | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 0.0 | 0.0 | 0.1 |
| ms4760-O | 0.0 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| He | 0.765 | 0.797 | 0.658 | 0.805 | 0.794 | 0.766 | 0.680 | 0.493 | |
He: expected heterozygosity.